CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy

Artificial receptors designed for adoptive immune therapies need to absolve dual functions: antigen recognition and abilities to trigger the lytic machinery of reprogrammed effector T lymphocytes. In this way, CAR-T cells deliver their cytotoxic hit to cancer cells expressing targeted tumor antigens...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacchetti, Benedetto, Botticelli, Andrea, Pierelli, Luca, Nuti, Marianna, Alimandi, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514830/
https://www.ncbi.nlm.nih.gov/pubmed/30999624
http://dx.doi.org/10.3390/ijms20081903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514830/
https://www.ncbi.nlm.nih.gov/pubmed/30999624
http://dx.doi.org/10.3390/ijms20081903

Ejemplares similares